The Food and Drug Administration inspected M & L Pharmaceutical, Inc. in San Bernardino on April 28, reviewing food composition, standards, labeling and econ, according to information on the FDA’s website.
The inspection’s final report noted there were no recommended corrective actions for M & L Pharmaceutical, Inc.’s operations management.
The FDA regularly examines facilities nationwide to ensure workplaces and products comply with FDA-regulated laws and rules designed to enhance public health. The agency then releases inspection outcomes to the public.
The FDA’s website states it is a federal agency overseeing the safety and quality of human and animal drugs, biological items, medical supplies and tobacco goods.
Details for this article came from the U.S. Food and Drug Administration. The original data is available here.
